Tech Company Financing Transactions
Abraxis BioScience Funding Round
Abraxis BioScience closed a $1.5 million venture capital round on 9/30/2008. Backers included Avalon Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$1,527,900
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11755 Wilshire Blvd 2000
Los Angeles, CA 90025
USA
Los Angeles, CA 90025
USA
Phone
Website
Email Address
Overview
Abraxis BioScience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics, such as ABRAXANE, and core technologies that offer patients and medical professionals safer and more effective treatments for cancer and other critical illnesses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Soon-Shiong
Executive Vice President
Bruce Wendel
VP - Finance
Mitchell Fogelman
Browse more venture capital transactions:
Prev: 9/30/2008: Secure Elements venture capital transaction
Next: 9/30/2008: PeopleTec venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs